New directions in cancer research 2003: Technological advances in biology, drug resistance, and molecular pharmacology

Michael E. Franks; Gordon R. Macpherson; Erin R. Lepper; William D. Figg; Alex Sparreboom

doi:10.1016/j.drup.2003.09.002

New directions in cancer research 2003: Technological advances in biology, drug resistance, and molecular pharmacology

Michael E. Franks, Gordon R. Macpherson, Erin R. Lepper, William D. Figg^*, Alex Sparreboom

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The 94th Annual Meeting of the American Association for Cancer Research (AACR) was held from July 11 to 14, 2003 in Washington, DC, and provided an overview of the latest developments in the field of cancer. This report provides highlights of presentations on array-based and RNA-interference technologies to study cancer biology and molecular pharmacology of anticancer drugs, mechanisms and modulation of drug resistance patterns, recent developments in the treatment of prostate cancer, and the medicinal chemistry of established and novel anticancer drugs.

Original language	English
Pages (from-to)	301-312
Number of pages	12
Journal	Drug Resistance Updates
Volume	6
Issue number	6
DOIs	https://doi.org/10.1016/j.drup.2003.09.002
State	Published - Dec 2003
Externally published	Yes

Keywords

Array-technology
Chemotherapy
Drug resistance
Novel targets
Prostate cancer

Access to Document

10.1016/j.drup.2003.09.002

Cite this

@article{826641fa3d9e46868017274bef6074e8,

title = "New directions in cancer research 2003: Technological advances in biology, drug resistance, and molecular pharmacology",

abstract = "The 94th Annual Meeting of the American Association for Cancer Research (AACR) was held from July 11 to 14, 2003 in Washington, DC, and provided an overview of the latest developments in the field of cancer. This report provides highlights of presentations on array-based and RNA-interference technologies to study cancer biology and molecular pharmacology of anticancer drugs, mechanisms and modulation of drug resistance patterns, recent developments in the treatment of prostate cancer, and the medicinal chemistry of established and novel anticancer drugs.",

keywords = "Array-technology, Chemotherapy, Drug resistance, Novel targets, Prostate cancer",

author = "Franks, {Michael E.} and Macpherson, {Gordon R.} and Lepper, {Erin R.} and Figg, {William D.} and Alex Sparreboom",

year = "2003",

month = dec,

doi = "10.1016/j.drup.2003.09.002",

language = "English",

volume = "6",

pages = "301--312",

journal = "Drug Resistance Updates",

issn = "1368-7646",

number = "6",

}

TY - JOUR

T1 - New directions in cancer research 2003

T2 - Technological advances in biology, drug resistance, and molecular pharmacology

AU - Franks, Michael E.

AU - Macpherson, Gordon R.

AU - Lepper, Erin R.

AU - Figg, William D.

AU - Sparreboom, Alex

PY - 2003/12

Y1 - 2003/12

N2 - The 94th Annual Meeting of the American Association for Cancer Research (AACR) was held from July 11 to 14, 2003 in Washington, DC, and provided an overview of the latest developments in the field of cancer. This report provides highlights of presentations on array-based and RNA-interference technologies to study cancer biology and molecular pharmacology of anticancer drugs, mechanisms and modulation of drug resistance patterns, recent developments in the treatment of prostate cancer, and the medicinal chemistry of established and novel anticancer drugs.

AB - The 94th Annual Meeting of the American Association for Cancer Research (AACR) was held from July 11 to 14, 2003 in Washington, DC, and provided an overview of the latest developments in the field of cancer. This report provides highlights of presentations on array-based and RNA-interference technologies to study cancer biology and molecular pharmacology of anticancer drugs, mechanisms and modulation of drug resistance patterns, recent developments in the treatment of prostate cancer, and the medicinal chemistry of established and novel anticancer drugs.

KW - Array-technology

KW - Chemotherapy

KW - Drug resistance

KW - Novel targets

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0842290920&partnerID=8YFLogxK

U2 - 10.1016/j.drup.2003.09.002

DO - 10.1016/j.drup.2003.09.002

M3 - Article

C2 - 14744494

AN - SCOPUS:0842290920

SN - 1368-7646

VL - 6

SP - 301

EP - 312

JO - Drug Resistance Updates

JF - Drug Resistance Updates

IS - 6

ER -

New directions in cancer research 2003: Technological advances in biology, drug resistance, and molecular pharmacology

Abstract

Keywords

Access to Document

Fingerprint

Cite this